Gabriel, R. Et Al. 2023. Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial. Journal of Clinical Medicine , vol.12, no.5 .

Gabriel, R., Boukichou-Abdelkader, N., Gilis-Januszewska, A., Makrilakis, K., Gómez-Huelgas, R., Kamenov, Z., ... Paulweber, B.(2023). Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial. Journal of Clinical Medicine , vol.12, no.5.

Gabriel, Rafael Et Al. "Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial," Journal of Clinical Medicine , vol.12, no.5, 2023

Gabriel, Rafael Et Al. "Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial." Journal of Clinical Medicine , vol.12, no.5, 2023

Gabriel, R. Et Al. (2023) . "Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial." Journal of Clinical Medicine , vol.12, no.5.

@article{article, author={Rafael Gabriel Et Al. }, title={Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial}, journal={Journal of Clinical Medicine}, year=2023}